Organon & Co. (OGN) is a publicly traded Healthcare sector company. As of July 18, 2026, OGN trades at $13.48 with a market cap of $3.54B and a P/E ratio of 14.39. OGN moved +0.22% today. Year to date, OGN is +88.56%; over the trailing twelve months it is +40.25%. Its 52-week range spans $5.69 to $17.23. Analyst consensus is neutral with an average price target of $14.00. Rallies surfaces OGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for OGN, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $13.48 |
| Market Cap | $3.54B |
| P/E Ratio | 14.39 |
| EPS | $0.94 |
| Dividend Yield | 0.02% |
| 52-Week High | $17.23 |
| 52-Week Low | $5.69 |
| Volume | 1.15M |
| Avg Volume | 0 |
| Revenue (TTM) | $6.16B |
| Net Income | $246.00M |
| Gross Margin | 52.81% |
2 analysts cover OGN: 0 strong buy, 0 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $14.00.